focu us economi begin reopen
rais est tp lh
life scienc tool diagnost minor model chang
seek pathway broader economi reopen covid serolog test
could increasingli signific role diagnost test activ viru
molecular test potenti immun covid serolog test increasingli
consid essenti tool support broader reopen economi
mani employ health offici begin convers lab provid includ
neutral labcorp lh outperform
lh recent announc new/revamp servic target employ support
large-scal workforc test serolog test well foster safer
workplac environ notabl view servic offer pathway increas
consist util molecular serolog test capac go forward
said test clearli import tool acknowledg mani question remain
particularli around antibodi test use broader reopen
economi includ question around accuraci extent antibodi
support immun durat immun among variabl detail
molecular serolog test capac across nation lab pleas see
recent updat diagnos state test part
rais estim tp lh light rise focu covid test
particularli given increas effort support employ bring employe back safe
workplac well seemingli improv test backdrop elect procedur begin
recov rais estim lh rais
ep respect
increment better expect test volum across serolog core test
meanwhil also rais ep estim lh
respect similarli better expect volum
expect partial off-set curtail margin expans importantli adjust
estim includ million million one-tim care act payout
us govern lh respect rais tp
lh respect higher
view risk includ reimburs pressur deal integr
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
labcorp america
life scienc tool diagnost
rais estim tp light rise focu covid test particularli given
increas effort support employ bring employe back safe workplac
well seemingli improv test backdrop elect procedur begin recov
rais estim lh rais ep estim
respect better expect
volum expect partial off-set curtail margin expans importantli
adjust estim includ million one-tim care act pay-out us
govern rais tp higher view risk
includ reimburs pressur deal integr
valuat metric
number share
 close
labcorp america lh
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
price
labcorp provid diagnost test inform servic clinic
better fundament perform sentiment could drive upsid
target price blue sky scenario lh
weaker fundament perform sentiment could lead downsid
versu target price grey sky scenario lh
 close
life scienc tool diagnost
rais estim tp light rise focu covid test particularli given
increas effort support employ bring employe back safe workplac
well seemingli improv test backdrop elect procedur begin recov
rais estim rais ep
respect increment better expect test
volum across serolog core test importantli adjust estim
includ million one-tim care act pay-out us govern
rais tp higher view risk includ
reimburs pressur deal integr
valuat metric
number share
 close
price
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
provid diagnost test informatin servic
better fundament perform could come faster organ
growth gain in-network statu sentiment could drive
upsid target price blue sky scenario
weaker fundament perform sentiment could lead downsid
versu target price grey sky scenario
 close
compani mention price
labcorp america lh outperform tp
erin wilson wright certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view
express report
